Cystic Fibrosis Canada is hosting a webinar series focused on answering your questions regarding the access to CF modulators in Canada.Read More
Infection Prevention and Control
An updated Cystic Fibrosis Foundation (U.S.A.) Infection Prevention and Control Guideline for people with CF, their families and health care professionals was published in the Society for Healthcare Epidemiology of America’s Infection Control & Hospital Epidemiology journal in July 2014. The updated guidelines have been endorsed by the Society for Healthcare Epidemiology of America (SHEA), the Association for Professionals in Infection Control and Epidemiology (APIC) and Cystic Fibrosis Canada’s Healthcare Advisory Council.
In response to these guidelines, Cystic Fibrosis Canada has developed an infection control policy for Cystic Fibrosis Canada hosted/sponsored meetings. Please note that this policy applies to all individuals with CF, including those who have undergone lung or liver transplant. Read more about the policy here.
For a tipsheet on understanding and communicating about CF infection prevention and control, please click here.
For the recommendations for healthcare professionals related to CF infection prevention and control, please click here.
For resources developed by the Cystic Fibrosis Foundation on infection prevention and control, please see below: